(NASDAQ: ACET) Adicet Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.92%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.8%.
Adicet Bio's earnings in 2026 is -$116,803,000.On average, 9 Wall Street analysts forecast ACET's earnings for 2026 to be -$107,783,965, with the lowest ACET earnings forecast at -$159,499,961, and the highest ACET earnings forecast at -$55,016,201. On average, 8 Wall Street analysts forecast ACET's earnings for 2027 to be -$97,198,168, with the lowest ACET earnings forecast at -$170,032,978, and the highest ACET earnings forecast at -$40,607,196.
In 2028, ACET is forecast to generate -$96,727,944 in earnings, with the lowest earnings forecast at -$189,594,294 and the highest earnings forecast at -$34,762,984.